Pretreatment quality-of-life score is a better discriminator of oesophageal cancer survival than performance status [THORACIC]

CONCLUSIONS In patients with Stage II–III oesophageal cancer being considered for curative therapy, pretreatment FACT-E and ECS have better discrimination for survival than does ECOG. The majority of patients were ECOG 0/1. Thus, these patient-derived scores were able to discriminate survivors from non-survivors even within this constrained range of clinician-assigned performance status. This highlights the potential utility of FACT-E and ECS as prognostic tools.

http://ejcts.oxfordjournals.org/cgi/content/short/51/1/148?rss=1

Source: European Journal of Cardio-Thoracic Surgery - January 10, 2017 Category: Cardiovascular & Thoracic Surgery Authors: Kidane, B., Sulman, J., Xu, W., Kong, Q., Wong, R., Knox, J. J., Darling, G. E. Tags: Cardiac - other, Esophagus - cancer THORACIC Source Type: research